Oculis to Present at Upcoming September Investor Conferences

Rhea-AI Summary

Oculis Holding AG (Nasdaq: OCS), a global biopharmaceutical company focused on eye care, has announced its participation in three major investor conferences in September 2024:

1. Wells Fargo Healthcare Conference (September 4-6, Boston, MA)
2. H.C. Wainwright 26th Annual Global Investment Conference (September 9-11, New York, NY)
3. Baird Global Healthcare Conference (September 10-11, New York, NY)

Key presentations include CEO Riad Sherif at H.C. Wainwright on September 11 at 9:30 am ET, and CFO Sylvia Cheung at Baird on September 10 at 9:05 am ET. The company will be available for one-on-one meetings during these events. Presentation links will be posted on Oculis' website under the Investors & Media section.

ZUG, Switzerland, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ management will be attending and presenting at the following upcoming investor conferences:

Wells Fargo Healthcare Conference 2024
Event dates: September 4-6, 2024
Location: Encore Boston Harbor, Boston, MA

H.C. Wainwright 26th Annual Global Investment Conference
Event dates: September 9-11, 2024
Company Presentation by Riad Sherif, MD, Chief Executive Officer on September 11 at 9:30 am ET
Location: Lotte New York Palace Hotel, NY, NY

Baird Global Healthcare Conference 2024
Event dates: September 10-11, 2024
Fireside Chat with Sylvia Cheung, Chief Financial Officer on September 10 at 9:05 am ET
Location: InterContinental New York Barclay, NY, NY

The Company will be available for one-on-one meetings during the conferences. Interested investors should contact their respective representative at the sponsoring institutions to request meetings. A link to access company presentation, when available, will be posted to Oculis website on the Events & Presentation page under the Investors & Media section.

About Oculis

Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) purposefully driven to save sight and improve eye care. Oculis’ highly differentiated pipeline comprises multiple innovative product candidates in development. It includes OCS-01, a topical eye drop candidate for diabetic macular edema (DME) and for the treatment of inflammation and pain following cataract surgery; OCS-02 (licaminlimab), a topical biologic anti-TNFα eye drop candidate for dry eye disease (DED) and for non-infectious anterior uveitis; and OCS-05, a neuroprotective candidate for acute optic neuritis (AON). Headquartered in Switzerland and with operations in the U.S. and Iceland, Oculis’ goal is to improve the health and quality of life of patients worldwide. The company is led by an experienced management team with a successful track record and is supported by leading international healthcare investors.

For more information, please visit: www.oculis.com

Oculis Contacts
Ms. Sylvia Cheung, CFO
sylvia.cheung@oculis.com

Investor & Media Relations
LifeSci Advisors
Corey Davis, Ph.D.
cdavis@lifesciadvisors.com
1-212-915-2577

FAQ

What investor conferences will Oculis (OCS) attend in September 2024?

Oculis (OCS) will attend three investor conferences in September 2024: Wells Fargo Healthcare Conference (September 4-6), H.C. Wainwright 26th Annual Global Investment Conference (September 9-11), and Baird Global Healthcare Conference (September 10-11).

When and where will Oculis CEO Riad Sherif present at the H.C. Wainwright conference?

Oculis CEO Riad Sherif will present at the H.C. Wainwright conference on September 11, 2024, at 9:30 am ET at the Lotte New York Palace Hotel in New York, NY.

What is the date and time of Oculis CFO Sylvia Cheung's fireside chat at the Baird conference?

Oculis CFO Sylvia Cheung will participate in a fireside chat at the Baird Global Healthcare Conference on September 10, 2024, at 9:05 am ET.

How can investors access Oculis (OCS) presentation materials from these conferences?

Investors can access Oculis (OCS) presentation materials on the company's website under the Events & Presentation page in the Investors & Media section when they become available.

Will Oculis (OCS) be available for one-on-one meetings during these September 2024 conferences?

Yes, Oculis (OCS) will be available for one-on-one meetings during the conferences. Interested investors should contact their representatives at the sponsoring institutions to request meetings.